205 related articles for article (PubMed ID: 23221619)
21. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
Pan J; Zhang Q; Liu Q; Komas SM; Kalyanaraman B; Lubet RA; Wang Y; You M
Cancer Prev Res (Phila); 2014 Nov; 7(11):1149-59. PubMed ID: 25245764
[TBL] [Abstract][Full Text] [Related]
22. PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes.
Smalley JP; Adams GE; Millard CJ; Song Y; Norris JKS; Schwabe JWR; Cowley SM; Hodgkinson JT
Chem Commun (Camb); 2020 Apr; 56(32):4476-4479. PubMed ID: 32201871
[TBL] [Abstract][Full Text] [Related]
23. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
Yuan Z; Liu H; Yan F; Wang Y; Gou L; Nie C; Ding Z; Lai S; Zhao Y; Zhao X; Li J; Deng H; Mao Y; Chen L; Wei Y; Zhao X
Cancer Sci; 2009 Sep; 100(9):1757-66. PubMed ID: 19575751
[TBL] [Abstract][Full Text] [Related]
24. Regulation of primitive hematopoiesis by class I histone deacetylases.
Shah RR; Koniski A; Shinde M; Blythe SA; Fass DM; Haggarty SJ; Palis J; Klein PS
Dev Dyn; 2013 Feb; 242(2):108-21. PubMed ID: 23184530
[TBL] [Abstract][Full Text] [Related]
25. Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non-small cell lung cancer tumorigenesis.
Guo Z; Tang Y; Wang S; Huang Y; Chi Q; Xu K; Xue L
Biofactors; 2024; 50(3):592-607. PubMed ID: 38149461
[TBL] [Abstract][Full Text] [Related]
26. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
Moody TW; Switzer C; Santana-Flores W; Ridnour LA; Berna M; Thill M; Jensen RT; Sparatore A; Del Soldato P; Yeh GC; Roberts DD; Giaccone G; Wink DA
Lung Cancer; 2010 May; 68(2):154-60. PubMed ID: 19628293
[TBL] [Abstract][Full Text] [Related]
27. Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC).
Zhang K; Liu Z; Yao Y; Qiu Y; Li F; Chen D; Hamilton DJ; Li Z; Jiang S
J Med Chem; 2021 Apr; 64(7):4020-4033. PubMed ID: 33745280
[TBL] [Abstract][Full Text] [Related]
28. Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer.
Luo L; Wu T; Ji M; Xiang J; Zou Y; Liao Y
Int Immunopharmacol; 2024 May; 133():112098. PubMed ID: 38626551
[TBL] [Abstract][Full Text] [Related]
29. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors.
Diamond JR; Pitts TM; Ungermannova D; Nasveschuk CG; Zhang G; Phillips AJ; Bagby SM; Pafford J; Yacob BW; Newton TP; Tentler JJ; Gittleman B; Hartman SJ; DeMattei JA; Winkler JD; Wendt MK; Schiemann WP; Eckhardt SG; Liu X; Piscopio AD
Mol Cancer Ther; 2022 Mar; 21(3):397-406. PubMed ID: 34965958
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts.
Chung YL; Troy H; Kristeleit R; Aherne W; Jackson LE; Atadja P; Griffiths JR; Judson IR; Workman P; Leach MO; Beloueche-Babari M
Neoplasia; 2008 Apr; 10(4):303-13. PubMed ID: 18392140
[TBL] [Abstract][Full Text] [Related]
32. Acetylation-mediated suppression of transcription-independent memory: bidirectional modulation of memory by acetylation.
Merschbaecher K; Haettig J; Mueller U
PLoS One; 2012; 7(9):e45131. PubMed ID: 23028801
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil Elastase Degrades Histone Deacetylases and Sirtuin 1 in Primary Human Monocyte Derived Macrophages.
Zheng S; Bulut GB; Kummarapurugu AB; Ma J; Voynow JA
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673851
[TBL] [Abstract][Full Text] [Related]
34. Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition.
Tseng YW; Yang TJ; Hsu YL; Liu JH; Tseng YC; Hsu TW; Lu Y; Pan SH; Cheng TR; Fang JM
Eur J Med Chem; 2024 Feb; 265():116042. PubMed ID: 38141287
[TBL] [Abstract][Full Text] [Related]
35. The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.
Ishii D; Shindo Y; Arai W; Konno T; Kohno T; Honda K; Miyajima M; Watanabe A; Kojima T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338691
[TBL] [Abstract][Full Text] [Related]
36. Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma.
Psilopatis I; Pergaris A; Giaginis C; Theocharis S
Dis Markers; 2021; 2021():7850688. PubMed ID: 34804263
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes.
Alshawli AS; Wurdak H; Wood IC; Ladbury JE
Mol Genet Genomic Med; 2020 Oct; 8(10):e1429. PubMed ID: 32720471
[TBL] [Abstract][Full Text] [Related]
38. Effects of histone acetyltransferase (HAT) and histone deacetylase (HDAC) inhibitors on proliferative, differentiative, and regenerative functions of Toll-like receptor 2 (TLR-2)-stimulated human dental pulp cells (hDPCs).
Fahmy SH; Jungbluth H; Jepsen S; Winter J
Clin Oral Investig; 2023 Dec; 28(1):53. PubMed ID: 38157054
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Approaches to Histone Reprogramming in Retinal Degeneration.
Berner AK; Kleinman ME
Adv Exp Med Biol; 2016; 854():39-44. PubMed ID: 26427391
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of HDAC10 inhibits POLE2-mediated DNA damage repair in NSCLC cells by increasing SP1 acetylation levels.
Guo H; Ren H; Han K; Li J; Dong Y; Zhao X; Li C
Pulm Pharmacol Ther; 2023 Dec; 83():102250. PubMed ID: 37657752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
